{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "transcribes",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:A6NDG6",
      "entity_text" : "P-gp",
      "entity_type" : "gene"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0095" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "While non-CYP-450 enzyme inducing AEDs such as levetiracetam, gabapentin, and lamotrigine may be preferable in cancer patients receiving chemotherapy, levetiracetam may be preferred as an initial option in the ICU as it is available for IV administration, does not appear to be affected by P-gp expression, and has favorable pharmacokinetic properties [XREF_BIBR, XREF_BIBR].",
  "reading_complete" : "2020-07-28T10:57:59Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T10:54:19Z",
  "trigger" : "expression",
  "evidence" : [ "P-gp expression" ],
  "pmc_id" : "7189427",
  "score" : 0
}